EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2

Jian Lou, Xueni Liu, Yanru Xie, Minhua Wu, Weibo Mao, Xiaozhen Ying

PeerJ · 05.11.2024 · 12 · e18324

DOI: 10.7717/peerj.18324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 05.11.2024. Verfasst von Jian Lou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Center, Lishui Central Hospital, Lishui, China. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Receptor, Transforming Growth Factor-beta Type II, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is a serious health threat to the patients. The present work explored the mechanism of miR-301b-3p and transforming growth factor-beta receptor 2 (TGFBR2 ) in affecting BC progression.

Methods

The miR-301b-3p-inhibitor and si-TGFBR2 solution were added to the DEME/F12 medium to culture the BC and normal breast epithelial cell lines to prepare negative control, miR-301b-3p-IN and miR-301b-3p-IN+si-TGFBR2 in the two types of cell lines. The relative expression of target genes and the interference effect were analyzed by quantitative real-time PCR (qRT- PCR). Cell viability was detected applying cell counting kit-8 (CCK-8) assay. Transwell and wound healing assay were conducted to evaluate the invasion and migration of BC cells after miR-301b-3p inhibition. Additionally, cell apoptosis and the expression STAT protein were measured by flow cytometry and Western blot, respectively Results The qRT-PCR results showed that miR-301b-3p were high-expressed but the level of TGFBR2 was significantly inhibited in BC cells. The miR-301b-3p-inhibitor significantly downregulated the expression of miR-301b-3p and upregulated that of TGFBR2. Meanwhile, inhibition of miR-301b-3p suppressed the cell viability, invasion, and migration of BC cells, which, however, were restored by the inhibition of TGFBR2. MiR-301b-3p conferred anti-apoptosis ability to BC cells, while TGFBR2 promoted apoptosis of BC cells through producing an antagonistic effect with miR-301b-3p. We found that miR-301b-3p played a crucial role in the phosphorylation of STAT1 and STAT3 to promote BC progression.

Conclusion

The present findings demonstrated that miR-301b-3p played a crucial role in promoting BC cell growth, invasion and migration and anti-apoptosis, and that targeting TGFBR2 could inhibit the tumor-promoting effect of miR-301b-3p.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsReceptor, Transforming Growth Factor-beta Type IIApoptosisCell MovementGene Expression Regulation, NeoplasticHumansFemaleCell Line, TumorCell ProliferationCell Survival

Stichwörter der Autor:innen

Antagonism of miR-301b-3p and TGFBR2Breast cancerMiR-301b-3p-inhibitorTransforming growth factor-beta receptor 2 (TGFBR2)Transwell assay

Substanzen

MicroRNAsReceptor, Transforming Growth Factor-beta Type IITGFBR2 protein, humanMIRN301A microRNA, human

Autor:innen und Institutionen

  • Tumor Center, Lishui Central Hospital, Lishui, China.
  • Pathology Department, Lishui Central Hospital, Lishui, China.

Zitieren

APA

Lou, J., Liu, X., Xie, Y., Wu, M., Mao, W., & Ying, X. (2024). MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2. PeerJ, 12, e18324. https://doi.org/10.7717/peerj.18324

Vancouver

Lou J, Liu X, Xie Y, Wu M, Mao W, Ying X. MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2. PeerJ. 2024;12:e18324. doi:10.7717/peerj.18324

BibTeX
@article{Lou2024,
  author = {Lou, Jian and Liu, Xueni and Xie, Yanru and Wu, Minhua and Mao, Weibo and Ying, Xiaozhen},
  title = {MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e18324},
  doi = {10.7717/peerj.18324}
}
Kostenlos starten →